UTI Healthcare Fund - Regular Plan - Growth Option

(Erstwhile UTI Pharma & Healthcare Fund-Growth Option)

Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 05-08-2005
Asset Class: Equity
Benchmark: S&P BSE Healthcare TRI
Expense Ratio: 2.6% As on (30-06-2022)
Status: Open Ended Schemes
Minimum Investment: 5000.0
Minimum Topup: 1000.0
Total Assets: 683.45 Cr As on (30-06-2022)
Turn over: 35.00
NAV as on 08-08-2022

148.8104

0.36 (0.2448%)

CAGR Since Inception

13.15%

S&P BSE Healthcare TRI 12.25%

PERFORMANCE of UTI Healthcare Fund - Regular Plan - Growth Option

Scheme Performance (%) Data as on - 08-08-2022

1-Year Ret (%) 3-Yrs Ret (%) 5-Yrs Ret (%) 10-Yrs Ret (%) Since Launch Ret (%)
UTI Healthcare Fund - Regular Plan - Growth Option -12.07 23.71 12.1 12.95 13.15
S&P BSE Healthcare TRI -11.82 18.03 9.07 11.52 12.25
Equity: Sectoral-Pharma and Healthcare -9.57 24.7 13.62 14.65 14.53

Yearly Performance (%)

Nav Movement

Fund Managers

V Srivatsa,Kamal Gada

Investment Objective

An open-end fund which exclusively invests in the equities of the pharma & healthcare sector companies. This fund is one of the growth sector fund s aiming to invest in companies engaged in business of manufacturing and marketing of bulk drug, formulations and health care products and service.

RETURNS CALCULATOR for UTI Healthcare Fund - Regular Plan - Growth Option

Growth of 10000 In SIP (Fund vs Benchmark)

Amount :
Period :
Start :
End :

Growth of 10000 In LUMPSUM (Fund vs Benchmark)

Amount :
Start :

Rolling Returns

Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.

Riskometer

Key Performance and Risk Statistics of UTI Healthcare Fund - Regular Plan - Growth Option

Key Statistics Volatility Sharpe Ratio Alpha Beta Yield to Maturity Average Maturity
UTI Healthcare Fund - Regular Plan - Growth Option 15.99 0.84 1.96 0.93 - -
Equity: Sectoral-Pharma and Healthcare - - - - - -

PEER COMPARISION of UTI Healthcare Fund - Regular Plan - Growth Option

Period
Data as on - 08-08-2022
Scheme Name Launch
Date
1-Year
Ret (%)
2-Yrs
Ret (%)
3-Yrs
Ret (%)
5-Yrs
Ret (%)
10-Yrs
Ret (%)
UTI Healthcare Fund - Regular Plan - Growth Option 05-08-2005 -12.07 10.29 23.71 12.1 12.95
Mirae Asset Healthcare Fund -Regular Growth 10-07-2018 -7.33 15.65 29.21 0.0 0.0
DSP Healthcare Fund - Regular Plan - Growth 05-11-2018 -7.47 13.83 28.76 0.0 0.0
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 28-12-2015 -7.48 13.82 23.25 14.06 0.0
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 05-07-2018 -8.87 13.65 26.23 0.0 0.0
SBI Healthcare Opportunities Fund - Regular Plan -Growth 14-07-1999 -9.57 12.52 24.93 11.15 14.78
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth 05-07-2019 -10.96 10.14 19.32 0.0 0.0
Nippon India Pharma Fund-Growth Plan-Growth Option 01-06-2004 -10.99 14.05 25.75 17.18 16.22
IDBI Healthcare Fund - Regular Plan - Growth 22-02-2019 -11.43 8.35 21.1 0.0 0.0

PORTFOLIO ANALYSIS of UTI Healthcare Fund - Regular Plan - Growth Option

Asset Allocation (%)